// App-Quantinova.ai

417 : Treating Spondyloarthritis Early: Does It Matter? Results from a Systematic Literature Review

Researchers

Presenter

  • Dafne Capelusnik

Principal Investigators

  • Diego Benavent

  • Désirée van der Heijde

  • Robert Landewé

  • Denis Poddubnyy

  • Astrid van Tubergen

  • Louise Falzon

  • Victoria Navarro-Compán

  • Sofia Ramiro

Medical Centers

  • Instituto de Rehabilitaciόn Psicofísica (IREP), Buenos Aires

  • La Paz University Hospital, Madrid, Spain

  • Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands, Leiden, Netherlands

  • VU University Medical Center, Amsterdam, Netherlands

  • Medical Department for Gastroenterology, Infectious Diseases and Rheumatology, Charite - Universitatsmedizin Berlin, Berlin, Germany

  • Maastricht University, Maastricht, Netherlands

  • Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom

  • Department of Hematology, La Paz University Hospital‐IdiPaz, Madrid

  • Leiden University Medical Centre, Leiden, Netherlands

Locations

  • Argentina

  • Spain

  • Netherlands

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Spondyloarthritis

  • Axial spondyloarthritis

Biomarkers

  • Cancer antigen 15-3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved